CLINICAL_TRIALS
trial_result
· 2018-09-19
Clinical Trial Update: Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of fingolimod in pediatric multiple sclerosis patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2018-09-19